SEARCH

SEARCH BY CITATION

References

  • 1
    Evans CS, Gooch L, Flotta D, Lykins D, Powers RW, Landsittel D, et al. Cardiovascular system during the postpartum state in women with a history of preeclampsia. Hypertension 2011;58:5762.
  • 2
    Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003;22:20312.
  • 3
    ACOG practice bulletin. ACOG Committee on Practice Bulletins – Obstetrics: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:15967.
  • 4
    Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre eclampsia and risk for cardiovascular disease and cancer in later life: systematic review and meta analysis. BMJ 2007;335:9747.
  • 5
    Melchiorre K, Sutherland GR, Liberati M, Thilaganathan G. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011;58:70915.
  • 6
    Gifford RW, August PA, Cunningham G, Green LA, Lindheimer MD, McNellis D, et al. National high blood pressure education program working group on high blood pressure in pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S122.
  • 7
    Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 2012;125:e2220.
  • 8
    Van Rijn BB, Nijdam ME, Bruinse HW, Roest M, Uiterwaal CS, Grobbee DE, et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol 2013;121:10408.
  • 9
    Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2008;200:58.e1–8.
  • 10
    Manten GTR, Sikkema MJ, Voorbij HAM, Visser GHA, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2007;26:3950.
  • 11
    Hermes W, Franx A, van Pampus MG, Bloemenkamp KWM, Bots ML, van dPJ, et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am J Obstet Gynecol 2013;208:474.e1–e8.
  • 12
    Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre eclampsia: systematic review and meta analysis. Eur J Epidemiol 2013;28:119.
  • 13
    Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:183747.
  • 14
    National Health and Medical Research Council (NHMRC). Guidelines for the assessment of absolute cardiovascular disease risk. 2009. Available from: www.heartfoundation.org.au/SiteCollectionDocuments/guidelines-Absolute-risk.pdf. Accessed 2 January 2014.
  • 15
    Greenland P, Alpert J, Beller GA, Benjamin EF, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50103.
  • 16
    Hermes W, Tamsma JT, Grootendorst DC, Franx A, van der Post J, van Pampus MG, et al. Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up study. BMC Pregnancy Childbirth 2013;13:126.
  • 17
    Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the avon longitudinal study of parents and children. Circulation 2012;125:136780.
  • 18
    Smith GN, Pudwell J, Walker M, Wen S. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can 2012;34:8305.
  • 19
    Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001;20:914.
  • 20
    D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:74353.
  • 21
    Framingham Heart Study. General Cardiovascular Disease (10-year risk) (based on D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117:743–53.) 2014 Available from: www.framinghamheartstudy.org/risk-functions/cardiovascular-disease/10-year-risk.php. Accessed 19 May 2014.
  • 22
    Framingham Heart Study. Cardiovascular Disease (30-year risk) (based on Pencina MJ, D'Agostino RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease. The Framingham Heart Study. Circulation 2009;119:3078–3084.) 2014 Available from: www.framinghamheartstudy.org/risk-functions/cardiovascular-disease/30-year-risk.php. Accessed 19 May 2014.
  • 23
    Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: The Framingham Heart Study. Circulation 2009;119:307884.
  • 24
    Berks D, Hoedjes M, Raat H, Duvekot JJ, Steegers EAP, Habbema JDF. Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature – based study. BJOG 2013;120:92431.
  • 25
    Sayin MR, Cetiner MA, Karabag T, Akpinar I, Sayin E, Kurcer MA, et al. Framingham risk score and severity of coronary artery disease. Herz 2013;16.
  • 26
    Barroso LC, Muro EC, Herrera ND, Ochoa GF, Hueros JIC, Buitrago F. Performance of the framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study. Scand J Prim Health Care 2010;28:2428.
  • 27
    Giavarina D, Barzon E, Cigolini M, Mezzena G, Soffiati G. Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts. Nutr Metab Cardiovasc Dis 2007;17:31118.
  • 28
    Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology. J Hypertens 2013;31:192538.
  • 29
    Mancia G, Grassi G. Management of essential hypertension. Br Med Bull 2010;94:18999.
  • 30
    Lim S. Recent update in the management of hypertension. Acta Med Indones 2007;39:18691.
  • 31
    Israili ZH, Hernández-Hernández R, Valasco M. The future of antihypertensive treatment. Am J Ther 2007;14:12134.
  • 32
    World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: WHO, 2002.
  • 33
    Rehman A, Schiffrin EL. Vascular effects of antihypertensive drug therapy. Curr Hypertens Rep 2010;12:22632.
  • 34
    Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007;25:110587.
  • 35
    Quan A, Kerlikowske K, Gueyffier F, Boissel JP. Efficacy of treating hypertension in women. J Gen Intern Med 1999;14:71829.
  • 36
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:190313.
  • 37
    Elliott WJ. The economic impact of hypertension. J Clin Hypertens (Greenwich) 2003;5(3 suppl 2):313.
  • 38
    Perk J, de Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WMM, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012;33:6351701.
  • 39
    Melchiorre K, Thilaganathan B. Maternal cardiac function in preeclampsia. Curr Opin Obstet Gynecol 2010;23:4407.
  • 40
    Ghossein-Doha C, Peeters L, van Heijster S, van Kuijk S, Spaan J, Delhaas T, et al. Hypertension after preeclampsia is preceded by changes in cardiac structure and function. Hypertension 2013;62:38290.
  • 41
    Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:155762.
  • 42
    Schelleman H, Klungel OH, Kromhout D, de Boer A, Stricker B. Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Hum Hypertens 2004;18:31724.
  • 43
    Nijdam ME, Timmerman MR, Franx A, Bruinse HW, Numans ME, Grobbee DE, et al. Cardiovascular risk factor assessment after pre-eclampsia in primary care. BMJ Fam Pract 2009;10:77.